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Introduction
Ornidazole, a synthetic nitroimidazole derivative, is
widely used in clinical practice. Ornidazol has low rate
of side effects, but sometimes may cause significant
allergic reactions such as fixed drug eruption (FDE). We
describe a case of multifocal FDE caused by ornidazole.
Case report
A 40-year old woman applied to the Immunology and
Allergy clinic with pruritic erythematous lesions over the
lateral sides of both arms and right hip within 30 minutes
after the ingestion of ornizadole 500 mg tablet. She
reported that five recurrent reactions emerged with the
same drug on the same locations previously, and their
severity was increased consecutively. She was prescribed
ornidazole for trichomonal vaginitis and she never
warned physicians about the previous drug reactions. In
view of the personal history and physical examination a
diagnosis of FDE due to ornidazole was diagnosed. After
a month from the last reaction allergy tests including
prick, intradermal and patch tests were performed with
ornidazole and metranidazole. Skin tests with 1/100 W/
vol and 1/10 W/vol concentrations and undiluted form
of the two drugs were negative. The patch tests consisted
of the same drug concentrations were applied to the
lesion site on her left arm. Readings were done at
48 hour later and positive results were obtained with
ornidazole but not with metranidazole. A placebo con-
trolled oral challenge was performed with metranidazole
and no reaction was observed. Following, she contunied
to receive metranidazole without any problem.
Conclusion
The lesionel patch test is more diagnostic than other
allergy tests at recürrent fixed drug reactions. The patch
test may be performed with the same drug solutions as
performed on skin prick and intradermal tests without
adding petrolatum. Although metronidazole and ornida-
zole are chemically related drugs, and metranidazole is
known more susceptible to cause FDE, metranidazole
may be an alternative drug to ornidazole like our case.
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